Portal de Periódicos da CAPES

Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection

2021; BMJ; Volume: 9; Issue: 1 Linguagem: Inglês

10.1136/bmjdrc-2020-002026

2052-4897

Arsenio Vargas‐Vázquez, Omar Yaxmehen Bello‐Chavolla, Edgar Ortíz‐Brizuela, Alejandro Campos-Muñoz, Roopa Mehta, Marco Villanueva-Reza, Jessica Paola Bahena-López, Neftalí Eduardo Antonio-Villa, María Fernanda González-Lara, Alfredo Ponce‐de‐León, José Sifuentes‐Osornio, Carlos A. Aguilar‐Salinas,

Diabetes Management and Research

Diabetes and hyperglycemia are risk factors for critical COVID-19 outcomes; however, the impact of pre-diabetes and previously unidentified cases of diabetes remains undefined. Here, we profiled hospitalized patients with undiagnosed type 2 diabetes and pre-diabetes to evaluate its impact on adverse COVID-19 outcomes. We also explored the role of de novo and intrahospital hyperglycemia in mediating critical COVID-19 outcomes.